Introduction: The purpose of this study was to evaluate and compare complications after radical cystectomy in patients aged ≥75 years. Materials and Methods: 251 patients aged 75-95 years (median 79) underwent radical cystectomy between 2000 and 2012 at four institutions. The patients were divided into two groups: ≥75-84 years of age (group 1) versus ≥85 years of age (group 2). Comorbidities, body mass index, and complications were obtained retrospectively, except at the Central Hospital of Bolzano and Weill Cornell Medical Center, which collected data prospectively. Cancer-specific survival, overall mortality, hospital stay, clinical outcome and complications were assessed. Complications were categorized using the Clavien-Dindo classification reporting system. The mean follow-up was 21 months. Results: The median hospital stay was 17 (2-91) days. Perioperative Clavien-Dindo grade ≥III complications were seen in 24.1% (48/199) of group 1 patients and 19.2% (10/52) of group 2 patients (p = 0.045). 30- and 90-day mortality was 4.5 and 13.5% in group 1 and 6.5 and 32.3% in group 2, respectively. Only the 90-day mortality rate was statistically significant (p < 0.05) between the two groups. The 3-year overall survival was 40% in group 1 and 34% in group 2. The 3-year cancer-specific survival was 52% in group 1 and 50% in group 2. Conclusions: We evaluated a large series of elderly (≥75 years) patients undergoing radical cystectomy at four institutions. Comparing patients aged ≥75-84 and ≥85 years revealed no significant difference in complications, 30-day mortality, overall and cancer-specific survival rates. Only 90-day mortality rates were significantly higher in the ≥85-year-old patients.

Keywords:
Elderly, Radical cystectomy, Bladder cancer, Complications, Clavien-Dindo classification
1.
Shariat SF, Lee R, Lowrance WT, et al: The effect of age on bladder cancer incidence, prognosis and therapy. Aging Health 2010;6:649-659.
2.
Shalhoub PJ, Quek ML: Management of bladder cancer in the elderly: clinical decision-making and guideline recommendations. Aging Health 2010;6:607-610.
3.
Ferlay J, Autier P, Boniol M, et al: Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581-592.
4.
International Agency for Research on Cancer. http://globocan.iarc.fr/6/7/2011.
5.
Schulzel M, Saltzstein SL, Downs TM, et al: Late age (85 years or older) incidence of bladder cancer. J Urol 2008;179:1302-1306.
6.
Statistik Austria: Krebsinzidenz und Krebsmortalität in Österreich. http://www.statistik.at/web_de/Redirect/index.htm?dDocName=050212, p 64.
7.
Madersbacher S, Hochreiter W, Burkhard F, Thalmann GN, Danuser H, Markwalder R, Studer UE: Radical cystectomy for bladder cancer today - a homogeneous series without neoadjuvant therapy. J Clin Oncol 2003;21:690-696.
8.
Roghmann F, Noldus J, von Bodman C, Holz A, Brock M, Palisaar J: Cystectomy in elderly patients: analysis of complications using the Clavien-Dindo classification. Urologe A 2012;51:1386-1392.
9.
Hollenbeck BK, Miller DC, Taub D, Dunn RL, Underwood W 3rd, Montie JE, Wei JT: Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. Urology 2004;64:292-297.
10.
Shariat SF, Milowsky M, Droller MJ: Bladder cancer in the elderly. Urol Oncol 2009;27:653-667.
11.
Froehner M, Brausi MA, Herr HW, Muto G, Studer U: Complications following radical cystectomy for bladder cancer in the elderly. Eur Urol 2009;56:443-454.
12.
Wehrberger C, Berger I, Marszalek M, Ponholzer A, Wehrberger M, Rauchenwald M, Madersbacher S: Bladder preservation in octogenarians with invasive bladder cancer. Urology 2010;75:370-375.
13.
Tyritzis SI, Anastasiou I, Stravodimos KG, Alevizopoulos A, Kollias A, Balangas A, Katafigiotis I, Leotsakos I, Mitropoulos D, Constantinides CA: Radical cystectomy over the age of 75 is safe and increases survival. BMC Geriatr 2012;12:18.
14.
Shabsigh A, Korets R, Vora KC, et al: Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 2009;55:164-176.
15.
Fairey A, Chetner M, Metcalfe J, Moore R, Todd G, Rourke K, Voaklander D, Estey E: Associations among age, comorbidity and clinical outcomes after radical cystectomy: results from the Alberta Urology Institute radical cystectomy database. J Urol 2008;180:128-134.
16.
Shariat SF, Godoy G, Lotan Y, et al: Advanced patients age is associated with inferior cancer-specific survival after radical nephroureterectomy. BJU Int 2010;105:1672-1677.
17.
Shariat SF, Sfakianos JP, Droller MJ, et al: The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int 2010;105:300-308.
18.
Witjes JA, Compérat E, Cowan NC, De Santis M, Gakis G, Lebret T, Ribal MJ, Sherif A: Guidelines on Muscle-Invasive and Metastatic Bladder Cancer. European Association of Urology, 2013. http://www.uroweb.org/gls/pdf/07_Bladder%20Cancer_LRV2.pdf.
19.
Dindo D, Demartines N, Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort of 6,336 patients and results of a survey. Ann Surg 2004;240:205-213.
20.
Pycha A, Comploj E: The dilemma of cystectomy in old-old and oldest-old patients. Expert Rev Anticancer Ther 2011;11:1863-1870.
21.
Yancik R, Ganz PA, Varricchio CG, Conley B: Perspectives on comorbidity and cancer in older patients: approaches to expand the knowledge base. J Clin Oncol 2001;19:1147-1151.
22.
Messing E: Urothelial tumors of the bladder; in Wein AJ (ed): Campell-Walsh Urology, ed 9. Philadelphia, Elsevier, 2008, p 2409.
23.
Donat SM, Siegrist T, Cronin A, Savage C, Milowsky MI, Herr HW: Radical cystectomy in octogenarians - does morbidity outweigh the potential survival benefits? J Urol 2010;183:2171-2177.
24.
Novotny V, Hakenberg OW, Froehner M, et al: Systemic assessment of complications and outcome of radical cystectomy undertaken with curative intent in patients with comorbidity and over 75 years of age. Urol Int 2013;90:195-201.
25.
Kulkarni JN: Perioperative morbidity of radical cystectomy: a review. Indian J Urol 2011;27:226-232.
26.
Hollenbeck BK, Taub DA, Miller DC, Dunn RL, Montie JE, Wei JT: The regionalization of radical cystectomy to specific medical centers. J Urol 2005;174:1385-1389.
27.
Gamé X, Soulié M, Seguin P, Vazzoler N, Tollon C, Pontonnier F, Plante P: Radical cystectomy in patients older than 75 years: assessment of morbidity and mortality. Eur Urol 2001;39:525-529.
28.
Lee KL, Freiha F, Presti JC Jr, Gill HS: Gender differences in radical cystectomy: complications and blood loss. Urology 2004;63:1095-1099.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.